Articles From: - Cybercrime Expert Brian Krebs to Deliver Keynote at Guidance Software’s CEIC 2015 to - What to look for in Walgreen's earnings

Guidance Software , (NASDAQ:GUID), the World Leader in Digital Investigations™, announced today that Brian Krebs , the leading cybersecurity investigative journalist who broke the story of the Target breach, will be the keynote speaker at CEIC® 2015 , May 18-21 in Las Vegas.
Sign-up for - Cybercrime Expert Brian Krebs to Deliver Keynote at Guidance Software’s CEIC 2015 investment picks
BURLINGTON, Mass., Sept.
Sign-up for - Global Technology Provider for Manufacturers Launches New Website on iAPPS Platform investment picks
Wins Gold in Business-to-Business Products, Business or Competitive Intelligence Solution categories TYSONS CORNER, Va.
Sign-up for - MicroStrategy Honored with Gold Stevie® Awards at 2014 American Business Awards investment picks
Company's Ingredients Will Now Carry Non-GMO Project Verified Seal SCOTTSDALE, Ariz.
Sign-up for 2014/9/29 - Non-GMO Project Completes Independent Verification Process to Certify RiceBran Technologies Ingredients investment picks
A single ILUVIEN implant provides treatment for three years Alimera will hold a conference call Wednesday, October 1, at 8:30 a.m. to discuss the approval ATLANTA , Sept.
Sign-up for - Alimera Sciences Provides Details On FDA Approval Of ILUVIEN® As The First Long-Term Treatment For Diabetic Macular Edema investment picks
FY 2014 Results Were Boosted By Sharp Increases in Oilfield Automation and Furnaces Revenues, Improved Gross Margins, and an Operating Profit Versus Operating Loss in the Prior Year BEIJING , Sept.
Sign-up for - Recon Technology Reports Strong Gains in FY 2014 and Announces Growth Goals investment picks
Puma Biotechnology, Inc. (NYSE: PBYI), a development stage biopharmaceutical company, announced that positive initial data from the ongoing, open label Phase II clinical trial of its investigational drug PB272 (neratinib) for the treatment of patients with non-small cell lung cancer (NSCLC) with HER2 mutations was presented today as a late-breaking oral presentation at the European Society for Medical Oncology (ESMO) 2014 Congress, taking place in Madrid, Spain.
Sign-up for - Puma Biotechnology Announces Positive Initial Results from PB272 Phase II Trial in HER2 Mutated Non-Small Cell Lung Cancer investment picks
2014/9/29 TORONTO, ONTARIO --
Sign-up for 2014/9/29 - BMO Small Business Confidence Report: Business Owners' Confidence Up from Spring investment picks
GNCC Capital, Inc. (OTC:GNCP) (“The Company”) announced today that its management and board of directors intend to recommend re-domiciling the Company as a Wyoming corporation.
Sign-up for - GNCC Capital, Inc. Re-Domiciling to Effect Stock Buyback Program investment picks
Clinigen Group plc (‘Clinigen’ or the ‘Group’, AIM:CLIN) the global specialty pharmaceutical company, today announces that it has received the first Drug Shortage Assistance Award from the US Food and Drug Administration (FDA) in recognition of its contribution in addressing a US shortage of Foscavir® (foscarnet sodium) injection.
Sign-up for - Clinigen Group plc Receives FDA’s First Ever Drug Shortage Assistance Award investment picks
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Western District of Pennsylvania on behalf of purchasers of Education Management Corporation (“EDMC” or the “Company”) (NASDAQ: EDMC) securities between August 8, 2012 and September 16, 2014, inclusive (the “Class Period”) and informs investors who wish to become proactively involved in the litigation that they have until November 18, 2014 to seek appointment as lead plaintiff.
Sign-up for - SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 from Investment in Education Management Corporation to Contact Brower Piven Before the November 18, 2014 Lead Plaintiff Deadline in Class Action Lawsuit investment picks
Westmoreland Coal Company (NasdaqGM:WLB) today announced that it has closed its offer to exchange up to $424 million of its 10.75% Senior Secured Notes due 2018 that have been registered under the Securities Act of 1933, as amended (the “Exchange Notes”), for up to $424 million of its outstanding 10.75% Senior Secured Notes due 2018 that were issued in a private placement on April 28, 2014 (the “Original Notes”). The exchange offer expired at 5:00 p.m., New York City time, on September 26, 2015.
Sign-up for 2014/9/29 - Westmoreland Announces Closing of Exchange Offer for 10.75% Senior Secured Notes due 2018 investment picks SAN FRANCISCO, CA --
Sign-up for - Oracle Announces New Innovations in Oracle Fusion Middleware, the Leading Cloud Platform for Today's Digital Business investment picks SAN JOSE, CA --
Sign-up for - Cal Water Launches Customer Hardship Grant Program investment picks
(All figures are in US dollars unless otherwise indicated) TORONTO , Sept.
Sign-up for - New Gold Announces Appointment of Chief Operating Officer investment picks
Monday, September 29, 2014 the Board of Directors of Dreyfus Strategic Municipals, Inc. (NYSE:LEO) declared from net investment income a monthly cash dividend of $0.049 per share of common stock, payable on October 31, 2014, to shareholders of record at the close of business on October 14, 2014.
Sign-up for - Dreyfus Strategic Municipals, Inc. (NYSE:LEO) Declares Dividend investment picks
2014/9/29 HAMILTON, BERMUDA --
Sign-up for 2014/9/29 - Teekay Corporation Intends to Increase Dividend by 75-80 Percent; Future Increases Linked to Growing Cash Flows from Two MLP Subsidiaries investment picks
SYNNEX Corporation (NYSE: SNX), a leading business process services company, today announced financial results for the fiscal third quarter ended August 31, 2014.
Sign-up for - SYNNEX Corporation Reports Fiscal 2014 Third Quarter Results investment picks
AllianzGI NFJ Dividend, Interest & Premium Strategy Fund (the "Fund") (NYSE:NFJ), a diversified closed-end management investment company which seeks current income and gains, with a secondary objective of long-term capital appreciation, today announced its results for the fiscal quarter and six months ended July 31, 2014.
Sign-up for - AllianzGI NFJ Dividend, Interest & Premium Strategy Fund Reports Results for the Fiscal Quarter and Six Months Ended July 31, 2014 investment picks
Sign-up for - Zions Bancorporation Announces Pricing of Pending Waterfall Tender Offer investment picks
The Rosen Law Firm, P.A. announces that it is investigating the Board of Directors of Athlon Energy Inc. (NYSE:ATHL) for possible breaches of fiduciary duty and other violations of law by failing to adequately shop Athlon Energy to maximize shareholder value before agreeing to be acquired by Encana Corporation (TSE:ECA). If you would like to join the action, go to or contact Phillip Kim or Kevin Chan, toll-free at 866-767-3653, or via e-mail at or .
Sign-up for - EQUITY ALERT: Rosen Law Firm Announces Investigation of Athlon Energy Inc. Concerning Its Proposed Sale to Encana Corporation – ATHL investment picks
Shareholder rights law firm Johnson & Weaver, LLP has commenced an investigation into whether certain officers and directors of Textura Corporation (NYSE:TXTR) violated state or federal laws.
Sign-up for - TEXTURA SHAREHOLDER ALERT: Shareholder Rights Law Firm Johnson & Weaver, LLP Continues Investigation of Textura Corporation investment picks
By Ciara Linnane, MarketWatch NEW YORK (MarketWatch) -- Walgreen Co.
Sign-up for - What to look for in Walgreen's earnings investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar

Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: - Cybercrime Expert Brian Krebs to Deliver Keynote at Guidance Software’s CEIC 2015 to - What to look for in Walgreen's earnings
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent